- H.R. 10171August 27, 2026
- H.R. 10156August 27, 2026
- H.R. 10172August 27, 2026
- H.R. 10160August 27, 2026
- H.R. 10181August 27, 2026
- H.R. 10176August 27, 2026
- H.Res. 1496August 27, 2026
- H.R. 10164August 27, 2026
- H.R. 10170August 27, 2026
- H.Res. 1494August 27, 2026
- H.R. 10163August 27, 2026
- H.R. 10157August 27, 2026
- AdministrationU.S. House
- AgricultureU.S. House
- Agriculture, Nutrition, And ForestryU.S. House
- AppropriationsU.S. House
- Armed ServicesU.S. House
- Banking, Housing, And Urban AffairsU.S. House
- BudgetU.S. House
- Commerce, Science, And TransportationU.S. House
- Education and WorkforceU.S. House
- Energy And CommerceU.S. House
- Energy And Natural ResourcesU.S. House
- Environment And Public WorksU.S. House
- EthicsU.S. House
- FinanceU.S. House
- Financial ServicesU.S. House
- Foreign AffairsU.S. House
- Foreign RelationsU.S. House
- Health, Education, Labor, And PensionsU.S. House
- Homeland SecurityU.S. House
- Homeland Security And Governmental Affa…U.S. House
- Indian AffairsU.S. House
- Indian and Insular AffairsU.S. House
- IntelligenceU.S. House
- JudiciaryU.S. House
- Natural ResourcesU.S. House
- Oversight And Government ReformU.S. House
- Permanent Select IntelligenceU.S. House
- RulesU.S. House
- Rules And AdministrationU.S. House
- Science, Space, And TechnologyU.S. House
- Select IntelligenceU.S. Senate
- Small BusinessU.S. House
- Small Business And EntrepreneurshipU.S. House
- Subcommittee on AviationU.S. House
- Subcommittee on Border Security and Enf…U.S. House
- Subcommittee on Coast Guard and Maritim…U.S. House
- Subcommittee on Commodity Markets, Digi…U.S. House
- Subcommittee on Conservation, Research,…U.S. House
- Subcommittee on Counterterrorism and In…U.S. House
- Subcommittee on Cybersecurity and Infra…U.S. House
- Subcommittee on Disability Assistance a…U.S. House
- Subcommittee on Economic Development, P…U.S. House
- Subcommittee on Economic OpportunityU.S. House
- Subcommittee on Emergency Management an…U.S. House
- Subcommittee on Energy and Mineral Reso…U.S. House
- Subcommittee on Federal LandsU.S. House
- Subcommittee on Forestry and Horticultu…U.S. House
- Subcommittee on General Farm Commoditie…U.S. House
- Subcommittee on HealthU.S. House
- Subcommittee on Highways and TransitU.S. House
- Subcommittee on Livestock, Dairy, and P…U.S. House
- Subcommittee on Nutrition and Foreign A…U.S. House
- Subcommittee on Oversight and Investiga…U.S. House
- Subcommittee on Oversight, Investigatio…U.S. House
- Subcommittee on Railroads, Pipelines, a…U.S. House
- Subcommittee on Transportation and Mari…U.S. House
- Subcommittee on Water Resources and Env…U.S. House
- Subcommittee on Water, Wildlife and Fis…U.S. House
- Transportation And InfrastructureU.S. House
- Veterans' AffairsU.S. House
- Ways And MeansU.S. House

H 8382
Rhode Island House•In House Committee
Summary
H 8382, which strengthens enforcement of the state's pharmacy audit law by clarifying and tightening audit procedures to ensure pharmacy audits are conducted fairly and transparently, was introduced in the House on Apr 1, 2026 by Rep. Rebecca Kislak (D) with 8 co-sponsors. It was referred to Health & Human Services, and last saw action on Apr 14, 2026: Committee recommended measure be held for further study.
Record
Text
H 8382 has 8 co-sponsors.
h8382/introduced.txt2026 -- H 8382========LC006204========STATE OF RHODE ISLANDIN GENERAL ASSEMBLYJANUARY SESSION, A.D. 2026____________AN ACTRELATING TO BUSINESSES AND PROFESSIONS -- PHARMACIESIntroduced By: Representatives Kislak, McGaw, Donovan, Corvese, Cruz, Giraldo,Potter, Fogarty, and StewartDate Introduced: April 01, 2026Referred To: House Health & Human Services(Attorney General)It is enacted by the General Assembly as follows:1SECTION 1. Section 5-19.1-35 of the General Laws in Chapter 5-19.1 entitled2 "Pharmacies" is hereby amended to read as follows:35-19.1-35. Audits.4(a) For the purposes of this section:5(1) “Audit” means a systematic review of provider claims, documentation, and billing6 practices, whether conducted remotely or on site, for the purported purpose of ensuring payments7 are made for covered, reasonable, and necessary services, or to detect fraud, waste, and abuse, or8 to recover overpayments.9(2) “Auditor” means a person or entity who conducts an audit as defined in subsection10 (a)(1) of this section.11(b) When an on-site audit of the records of a pharmacy is conducted by a carrier or its12 intermediary, the audit must be conducted in accordance with the following criteria:13(1) A finding of overpayment or underpayment must be based on the actual overpayment14 or underpayment, and not a projection based on the number of patients served having a similar15 diagnosis, or on the number of similar orders or refills for similar drugs, unless the projected16 overpayment or denial is a part of a settlement agreed to by the pharmacy or pharmacist;17(2) The auditor may not use extrapolation in calculating recoupments or penalties unless18 required by state or federal laws or regulations;19(3) Any audit that involves clinical judgment must be conducted by, or in consultation with,1 a pharmacist; and2(4) Each entity conducting an audit shall establish an appeal process under which a3 pharmacy may appeal an unfavorable preliminary audit report to the entity.4(b) This section does not apply to any audit, review, or investigation that is initiated based5 on or involving suspected or alleged fraud, willful misrepresentation, or abuse.6(c) Prior to an audit, the entity conducting an audit shall give the pharmacy fourteen (14)7 days advance written notice of the audit and the range of prescription numbers involved in the audit.8 The carrier or its intermediary may mask the last two digits of the numbers. Additionally, the9 number of prescriptions shall not exceed one hundred fifty (150) prescription claims and their10 applicable refills. The time allotted must be adequate to collect all samples. The examination of11 signature logs shall not exceed twenty-five (25) signature logs in number.12(d) A pharmacy has the right to execute the dispute resolution contained in their contract.13(e)(1) A preliminary audit report must be delivered to the pharmacy or its corporate office14 within sixty (60) days after the conclusion of the audit. A pharmacy must be allowed at least thirty15 (30) days following receipt of the preliminary audit report to provide documentation to address any16 discrepancy found in the audit. A final audit report must be delivered to the pharmacy or its17 corporate office within ninety (90) days after receipt of the preliminary audit report or final appeal,18 whichever is later. A charge-back recoupment or other penalty may not be assessed until the appeal19 process provided by the pharmacy benefits manager has been exhausted and the final report issued.20 If the identified discrepancy for a single audit exceeds twenty-five thousand dollars ($25,000),21 future payments in excess of that amount may be withheld pending the adjudication of an appeal.22 Auditors shall only have access to previous audit reports on a particular pharmacy conducted for23 the same entity.24(2) Auditors may initiate a desk audit prior to an on-site audit unless otherwise specified in25 the law.26(3)(2) Contracted auditors cannot be paid based on the findings within an audit.27(4)(3) Scanned images of all prescriptions including all scheduled controlled substances28 are allowed to be used by the pharmacist for an audit. Verbally received prescriptions must be29 accepted upon validation by the auditing entity and applicable for the initial desk or on-site audit.30(5)(4) The period covered by an audit may not exceed two (2) years.31(6)(5) Within five (5) business days of receiving the audit notification, pharmacies are32 allowed, at a minimum, one opportunity to reschedule with the auditor if the scheduled audit33 presents a scheduling conflict for the pharmacist.34(f) Any clerical error, typographical error, scrivener’s error, or computer error regarding aLC006204 - Page 2 of 51 document or record does not constitute a willful violation and is not subject to criminal penalties2 without proof of intent to commit fraud.3(g) Limitations.4(1) Exceptions. The Subject to subsection (g)(2) of this section, the provisions of this5 chapter do not apply to an investigative audit of pharmacy records when:6(i) Fraud, waste, abuse, or other intentional misconduct is indicated by physical review or7 review of claims data or statements; or8(ii) Other investigative methods indicate a pharmacy is or has been engaged in criminal9 wrongdoing, fraud, or other intentional or willful misrepresentation.10(2) Scope of exceptions.11(i) An audit for which an exception is applicable shall be strictly limited in scope to the12 issue(s) directly giving rise to the suspicions, allegations, or conduct indicated by other13 investigative methods. Before conducting an audit for which an exception is applicable, the auditor14 shall memorialize in writing the basis for any exception hereunder, which shall include a15 description of the specific issue(s) under review and facts giving rise to the audit, and shall make16 such writing available to the attorney general upon request.17(ii) The auditor may not rely solely on a finding of common control or common ownership18 as a basis for conducting an audit to which an exception applies with respect to a pharmacy, unless19 the auditor first confirms the presence of an identified systemic error, fraud, abuse, willful20 misrepresentation, or criminal wrongdoing with respect to a pharmacy under common control or21 common ownership.22(2)(3) Frequency of audits. A pharmacy shall not be subject to more than one on-site audit23 in connection with a carrier every twelve (12) months, unless there is an identified problem or24 substantial evidence of fraud, abuse, or misrepresentation is suspected, or other criminal25 wrongdoing.26(3)(4) Federal law. This chapter does not supersede any audit requirements established by27 federal law.28(5) Notice to the attorney general. Prior to initiating an audit pursuant to an exception under29 subsection (g)(1) of this section, the auditor shall provide written notice to the attorney general of30 their intent to conduct an audit pursuant to an applicable exception. Such notice shall be provided31 at least three (3) business days prior to the initiation of the audit.32(h) Enforcement. The Rhode Island attorney general shall have the authority to enforce33 and ensure compliance with this section.34(1) The attorney general may institute proceedings to prevent and restrain violations of thisLC006204 - Page 3 of 51 section. The superior court shall have jurisdiction to prevent and restrain violations of this section.2(2) In addition to injunctive relief, any person or entity in violation of this section shall be3 liable for a civil penalty, in an action brought by the attorney general, of not more than ten thousand4 dollars ($10,000) for each violation.5(3) The attorney general may promulgate rules and regulations to implement the provisions6 of this section.7SECTION 2. This act shall take effect upon passage.========LC006204========LC006204 - Page 4 of 5EXPLANATIONBY THE LEGISLATIVE COUNCILOFAN ACTRELATING TO BUSINESSES AND PROFESSIONS -- PHARMACIES***1This act would strengthen enforcement of the state's pharmacy audit law by clarifying and2 tightening audit procedures to ensure pharmacy audits are conducted fairly and transparently.3This act would take effect upon passage.========LC006204========LC006204 - Page 5 of 5
BUSINESSES AND PROFESSIONS -- PHARMACIES - Strengthens enforcement of the state's pharmacy audit law by clarifying and tightening audit procedures to ensure pharmacy audits are conducted fairly and transparently.
Sponsors
Rep. Rebecca Kislak (D) sponsors H 8382, and 8 members have co-sponsored it.

Rep. · D–4 · Sponsor

Rep. · D–71 · Co-sponsor

Rep. · D–69 · Co-sponsor

Rep. · D–55 · Co-sponsor

Rep. · D–58 · Co-sponsor

Rep. · D–56 · Co-sponsor

Rep. · D–16 · Co-sponsor

Rep. · D–35 · Co-sponsor

Rep. · D–59 · Co-sponsor
Committees
H 8382 went before 1 committee: Health & Human Services.
History
H 8382 has taken 3 actions since Apr 1, 2026, the latest on Apr 14, 2026.
| Chamber | Action | |||
|---|---|---|---|---|
Apr 14, 2026 | House | Committee recommended measure be held for further study | ||
Apr 10, 2026 | House | Scheduled for hearing and/or consideration (04/14/2026) | ||
Apr 1, 2026 | House | Introduced, referred to House Health & Human Services |
Votes
H 8382 has not gone to a roll call.
Source: status.rilegislature.gov · legiscan.com